The Health Utility and Valuation of Cosmetic Rhinoplasty

Overview

Health economics values interventions by how much quality-adjusted life they deliver per dollar. This cross-sectional survey applied those methods to cosmetic rhinoplasty, asking members of the public to imagine each photographed nose on their own face and to value having an ideal nose instead.

Sections of note

• Cross-sectional survey administered through public online forums to 161 casual observers in America.
• Participants viewed before and after photographs of six patients who had cosmetic rhinoplasty and two who had no surgery.
• They were asked to imagine the external nose in each image on their own face, then rate their health state utility and how much they would pay to have the ideal nose.
• Established metrics of standard gamble and visual analogue scale were used.
• Willingness to pay per quality-adjusted life year for cosmetic rhinoplasty was calculated at $12,264.
• That figure is significantly below cost-effective thresholds.
• Participants were willing to accept a 10 percent risk of death to undergo cosmetic rhinoplasty.

What it means for a patient

• By standard health economics measures, cosmetic rhinoplasty scores as a high-value intervention as judged by the public.
• The 10 percent accepted mortality risk is a hypothetical response, not a decision anyone made, but it indicates how strongly people weigh nasal appearance.
• The valuation reflects how observers imagine feeling with a given nose, not how patients actually feel.
• Limits: 161 online respondents, six patients photographed, hypothetical valuations, and an American sample.

Why this paper matters

Cosmetic procedures are excluded from health economic evaluation because they are self-funded and considered non-medical. Applying the standard metric shows the public values nasal appearance at levels comparable to funded interventions. Hypothetical willingness to pay and accepted risk are known to overstate real behavior.

Terms

• Health utility: A number between 0 and 1 expressing how good a health state is judged to be.
• Quality-adjusted life year: One year of life weighted by the quality of health during it.
• Willingness to pay: An economic method valuing a benefit by what people say they would pay.
• Standard gamble: A method that values a health state by what risk of death people would accept to escape it.
• Cost-effectiveness threshold: The cost per quality-adjusted life year below which an intervention is considered good value.